Fraud Lawsuit Against DePuy on Hip Device Defects Revived

Johnson & Johnson and its subsidiary DePuy Orthopaedics are faced with continued False Claims Act ligation after a federal appeals court partially reversed the dismissal of a whistle-blower lawsuit (United States ex rel. Nargol v. DePuy Orthopaedics, Inc., 2017 BL 258966, 1st Cir., No. 16-1442, 7/26/17).

The U.S. Court of Appeals for the First Circuit said July 26 that whistle-blowers Antoni Nargol and David Langton, two orthopedic surgeons, sufficiently alleged that DePuy knew one of its hip replacement medical devices wasn’t being manufactured according to standards approved by the Food and Drug ...